eSignal IPO Calendar

Week of Expected Pricing	pending
Company Name	FULCRUM THERAPEUTICS, INC.
Proposed Ticker	FULC
CUSIP	N/A
Business Description	A clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined diseases in areas of high unmet medical need, with an initial focus on rare diseases.
Lead Underwriter	BofA Securities, Inc ,Morgan Stanley & Co. LLC ,SVB Leerink LLC
Co-Managers	N/A
Initial Shares	N/A
Revised Initial Shares	N/A
Initial Price	N/A
Revised Price	N/A
Final Price	N/A
Final Ticker	N/A